NO20024924D0 - Anvendelse av bradykardiale substanser ved behandling av myokardiale sykdommer i forbindelse med hypertrofi og nyemedikamentkombinasjoner - Google Patents

Anvendelse av bradykardiale substanser ved behandling av myokardiale sykdommer i forbindelse med hypertrofi og nyemedikamentkombinasjoner

Info

Publication number
NO20024924D0
NO20024924D0 NO20024924A NO20024924A NO20024924D0 NO 20024924 D0 NO20024924 D0 NO 20024924D0 NO 20024924 A NO20024924 A NO 20024924A NO 20024924 A NO20024924 A NO 20024924A NO 20024924 D0 NO20024924 D0 NO 20024924D0
Authority
NO
Norway
Prior art keywords
bradycardial
hypertrophy
substances
treatment
connection
Prior art date
Application number
NO20024924A
Other languages
English (en)
Other versions
NO330311B1 (no
NO20024924L (no
Inventor
Juergen Daemmgen
Brian Guth
Randolph Seidler
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of NO20024924D0 publication Critical patent/NO20024924D0/no
Publication of NO20024924L publication Critical patent/NO20024924L/no
Publication of NO330311B1 publication Critical patent/NO330311B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20024924A 2000-04-13 2002-10-11 Bradykardiale substanser for behandling av myokardiale sykdommer som ledsages av hypertrofi. NO330311B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10018401A DE10018401A1 (de) 2000-04-13 2000-04-13 Verwendung von Bradycardica bei der Behandlung von mit Hypertrophie einhergehenden Myocarderkrankungen und neue Arzneimittelkombinationen
PCT/EP2001/004034 WO2001078699A2 (de) 2000-04-13 2001-04-07 Verwendung von bradycardica bei der behandlung von mit hypertrophie einhergehenden myocarderkrankungen und neue arzneimittelkombinationen

Publications (3)

Publication Number Publication Date
NO20024924D0 true NO20024924D0 (no) 2002-10-11
NO20024924L NO20024924L (no) 2002-10-11
NO330311B1 NO330311B1 (no) 2011-03-28

Family

ID=7638652

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024924A NO330311B1 (no) 2000-04-13 2002-10-11 Bradykardiale substanser for behandling av myokardiale sykdommer som ledsages av hypertrofi.

Country Status (33)

Country Link
US (2) US7208508B2 (no)
EP (2) EP1666042A3 (no)
JP (1) JP3905386B2 (no)
KR (1) KR20020089453A (no)
CN (1) CN1245963C (no)
AT (1) ATE330588T1 (no)
AU (2) AU2001270484B2 (no)
BG (1) BG65816B1 (no)
BR (1) BR0109996A (no)
CA (2) CA2404120C (no)
CY (1) CY1105081T1 (no)
CZ (1) CZ300549B6 (no)
DE (2) DE10018401A1 (no)
DK (1) DK1276476T3 (no)
EA (1) EA006977B1 (no)
EE (1) EE05099B1 (no)
ES (1) ES2266216T3 (no)
HR (1) HRP20020815A2 (no)
HU (1) HU228387B1 (no)
IL (2) IL152103A0 (no)
ME (1) MEP45908A (no)
MX (1) MXPA02009935A (no)
NO (1) NO330311B1 (no)
NZ (1) NZ521934A (no)
PL (1) PL215235B1 (no)
PT (1) PT1276476E (no)
RS (1) RS51478B (no)
SI (1) SI1276476T1 (no)
SK (1) SK286075B6 (no)
TR (1) TR200202326T2 (no)
UA (1) UA78679C2 (no)
WO (1) WO2001078699A2 (no)
ZA (1) ZA200208162B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10018401A1 (de) * 2000-04-13 2001-10-25 Boehringer Ingelheim Pharma Verwendung von Bradycardica bei der Behandlung von mit Hypertrophie einhergehenden Myocarderkrankungen und neue Arzneimittelkombinationen
TR200400127T4 (tr) * 2002-07-25 2004-02-23 Boehringer Ingelheim Pharma Gmbh & Co Kg Kalp yetmezliğinin tedavisinde veya önlenmesinde siloeradin veya bunun farmasötik açıdan kabul gören tuzları
US20040138306A1 (en) * 2002-07-25 2004-07-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
WO2004067003A1 (ja) * 2003-01-31 2004-08-12 Sankyo Company, Limited 動脈硬化及び高血圧症の予防及び治療のための医薬
TWI405580B (zh) * 2005-06-27 2013-08-21 Sankyo Co 含有血管收縮素ｉｉ接受器拮抗劑及鈣通道阻斷劑之醫藥調配物
EP1917979A4 (en) * 2005-08-23 2009-06-03 Astellas Pharma Inc THERAPEUTICS FOR PREVIOUS LIVING ROOMS
EP1762179A1 (en) * 2005-09-07 2007-03-14 Boehringer Ingelheim Vetmedica Gmbh Method for improving diagnostic quality in echocardiography
FR2894825B1 (fr) * 2005-12-21 2010-12-03 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent
TWI399223B (zh) * 2006-09-15 2013-06-21 Daiichi Sankyo Co Ltd 奧美沙坦酯及氨氯地平之固體劑型
EP1908469A1 (en) * 2006-10-06 2008-04-09 Boehringer Ingelheim Vetmedica Gmbh Angiotensin II receptor antagonist for the treatment of systemic diseases in cats
ES2598490T3 (es) 2009-05-20 2017-01-27 Boehringer Ingelheim Vetmedica Gmbh Disolución farmacéutica bebible de telmisartán
FR2961105B1 (fr) 2010-06-15 2013-02-08 Servier Lab Utilisation de l'association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion de l'angiotensine pour le traitement de l'insuffisance cardiaque
KR101296743B1 (ko) * 2011-02-17 2013-08-20 한국과학기술연구원 심근 비대증 진단용 바이오마커 및 이를 이용한 심근 비대증 진단 방법
KR20140053307A (ko) 2011-08-12 2014-05-07 베링거잉겔하임베트메디카게엠베하 맛이 차폐된 약제학적 조성물
EP2953612A1 (en) 2013-02-11 2015-12-16 Boehringer Ingelheim Vetmedica GmbH Kit-of-parts
KR20250007040A (ko) 2017-07-07 2025-01-13 베링거잉겔하임베트메디카게엠베하 고양이에서 전신 질환의 예방 또는 치료를 위한 안지오텐신 ii 수용체 길항제
KR102398532B1 (ko) 2020-07-20 2022-05-13 한림대학교 산학협력단 중증 지주막하출혈 진단용 조성물
KR102331806B1 (ko) 2020-07-20 2021-12-01 한림대학교 산학협력단 중증 지주막하출혈 진단용 바이오 마커

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759125A (fr) 1969-11-19 1971-05-18 Boehringer Sohn Ingelheim Nouvelles n-allyl-2-arylamino-imidazolines-(2) substituees et procedes pour les fabriquer
DE3119874A1 (de) 1981-05-19 1982-12-09 Dr. Karl Thomae Gmbh, 7950 Biberach "benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel"
DE3541811A1 (de) * 1985-11-27 1987-06-04 Thomae Gmbh Dr K Neue cyclische aminderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
US5175157A (en) 1985-11-27 1992-12-29 Boehringer Ingelheim Gmbh Cyclic amine derivatives, pharmaceutical compositions containing these compounds and methods for preparing them
DE3736866A1 (de) 1987-10-30 1989-05-11 Thomae Gmbh Dr K Mittel zur behandlung des bluthochdrucks und der herzinsuffizienz
DE3805635A1 (de) 1988-02-24 1989-09-07 Thomae Gmbh Dr K Verwendung von benzimidazolen zur herstellung eines arzneimittels mit antiischaemischen wirkungen am herzen und dessen kombinationen mit ss-blockern oder bradycardica
US5308853A (en) * 1991-12-20 1994-05-03 Warner-Lambert Company Substituted-5-methylidene hydantoins with AT1 receptor antagonist properties
RU2078536C1 (ru) * 1993-09-02 1997-05-10 Украинский научно-исследовательский институт кардиологии им.акад.Н.Д.Стражеско Способ определения клинической эффективности применения верапамила и дилтиазема у больных гипертрофической кардиомиопатией
CN1135757A (zh) 1993-09-24 1996-11-13 普罗克特和甘保尔公司 新型含脱氧和氧被取代的糖的14-氨基类固醇
US5595987A (en) * 1994-07-22 1997-01-21 The Trustees Of Columbia University In The City Of New York Method of slowing ventricular arrhythmias using zatebradine
US6083991A (en) * 1997-06-04 2000-07-04 University Of Florida Research Foundation, Inc. Anti-arrhythmic composition and methods of treatment
DE19741635A1 (de) 1997-09-22 1999-03-25 Hoechst Marion Roussel De Gmbh Biphenylsulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament
SK285863B6 (sk) * 1998-07-10 2007-10-04 Novartis Ag Kombinovaná farmaceutická kompozícia obsahujúca AT1-antagonistu valsartan a amlodipín
DE10018401A1 (de) 2000-04-13 2001-10-25 Boehringer Ingelheim Pharma Verwendung von Bradycardica bei der Behandlung von mit Hypertrophie einhergehenden Myocarderkrankungen und neue Arzneimittelkombinationen
CA2435526A1 (en) 2002-07-25 2004-01-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of cyclic amine derivatives or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
US20040138306A1 (en) * 2002-07-25 2004-07-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
EP1762179A1 (en) * 2005-09-07 2007-03-14 Boehringer Ingelheim Vetmedica Gmbh Method for improving diagnostic quality in echocardiography

Also Published As

Publication number Publication date
HRP20020815A2 (en) 2004-12-31
NO330311B1 (no) 2011-03-28
DK1276476T3 (da) 2006-08-14
BG107103A (bg) 2003-04-30
HUP0300917A2 (hu) 2003-08-28
MXPA02009935A (es) 2003-02-12
JP2003535050A (ja) 2003-11-25
IL152103A (en) 2008-07-08
IL152103A0 (en) 2003-07-31
EA200201053A1 (ru) 2003-02-27
CA2404120C (en) 2008-01-22
US7208508B2 (en) 2007-04-24
BR0109996A (pt) 2003-05-27
DE10018401A1 (de) 2001-10-25
PL215235B1 (pl) 2013-11-29
TR200202326T2 (tr) 2003-03-21
US20070155679A1 (en) 2007-07-05
EA006977B1 (ru) 2006-06-30
KR20020089453A (ko) 2002-11-29
JP3905386B2 (ja) 2007-04-18
US20040014795A1 (en) 2004-01-22
CN1422153A (zh) 2003-06-04
WO2001078699A3 (de) 2002-06-20
PT1276476E (pt) 2006-09-29
ZA200208162B (en) 2003-10-17
CZ20023752A3 (cs) 2003-03-12
PL357827A1 (en) 2004-07-26
CA2575059A1 (en) 2001-10-25
HUP0300917A3 (en) 2009-04-28
WO2001078699A2 (de) 2001-10-25
EP1666042A3 (de) 2006-06-21
EE200200590A (et) 2004-04-15
CN1245963C (zh) 2006-03-22
AU2001270484B2 (en) 2007-01-25
EP1276476B1 (de) 2006-06-21
CA2404120A1 (en) 2001-10-25
CZ300549B6 (cs) 2009-06-10
BG65816B1 (bg) 2010-01-29
SK286075B6 (sk) 2008-03-05
CY1105081T1 (el) 2009-11-04
MEP45908A (en) 2011-02-10
DE50110262D1 (de) 2006-08-03
NO20024924L (no) 2002-10-11
EP1276476A2 (de) 2003-01-22
SI1276476T1 (sl) 2006-10-31
EE05099B1 (et) 2008-12-15
ES2266216T3 (es) 2007-03-01
UA78679C2 (en) 2007-04-25
RS51478B (sr) 2011-04-30
ATE330588T1 (de) 2006-07-15
SK14582002A3 (sk) 2003-03-04
HU228387B1 (en) 2013-03-28
AU7048401A (en) 2001-10-30
EP1666042A2 (de) 2006-06-07
YU76902A (sh) 2006-05-25
NZ521934A (en) 2007-05-31

Similar Documents

Publication Publication Date Title
NO20024924D0 (no) Anvendelse av bradykardiale substanser ved behandling av myokardiale sykdommer i forbindelse med hypertrofi og nyemedikamentkombinasjoner
NO20022680L (no) Farmasoytiske kombinasjoner og deres anvendelse ved behandling av gastrointestinale forstyrrelser
NO20032695D0 (no) Karboksamidderivater og deres anvendelse ved behandling av tromboemboliskesykdommer
NO20023566D0 (no) Propionsyrederivater og deres anvendelse ved behandling av sukkkersyke og fedme
NO20034430D0 (no) Tiohydantoiner og anvendelse derav for behandling av diatbetes
NO20043370L (no) N-pyrazinylfenylsulfonamider og deres anvendelse ved behandling av kemokinmedierte sykdommer
EE200300165A (et) Fenofibraadi ja koensüüm Q10 kombinatsioon endoteeli düsfunktsiooni ravimiseks
AU2001270484A1 (en) Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations
AU2001283285A1 (en) Antimicrobial composition and methods of use in the treatment of disease
IS6966A (is) Cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
IS6967A (is) Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
GB0019302D0 (en) Biological materials and the use thereof for the treatment of disease
NO20030295L (no) Anvendelse av derivater av valproinsyre- og 2- valproensyreamider for behandling av manier ved bipolare lidelser
NO20020031D0 (no) Dihydrobenzodiazepiner og deres anvendelse ved behandling av dyslipidemi
DK1341786T3 (da) Substituerede derivater af aminofuran-2-yl-eddikesyre og aminothien-2-yl-eddikesyre og anvendelsen deraf til behandling af migræner og smerte
NO20043295L (no) Faste salt-benzazepinforbindelser og deres anvendelse ved fremstilling av farmasoytiske forbindelser
NO20020207D0 (no) Biologiske materialer og fremgangsmåter som er nyttige ved diagnostisering og behandling av sykdom
NO20043029L (no) Karboksamidinderivater og deres anvendelse ved behandling av vaskulaere sykdommer
GB0007217D0 (en) Materials and methods relating to the treatment of leukaemias
AU2003270350A1 (en) Isoxazoles and their use in the treatment of ischemic diseases
AU2003244455A1 (en) Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases
NO985974D0 (no) Piperidineddiksyrederivater og deres anvendelse ved behandling av trombose-sykdommer
IS6660A (is) Ný bispídínefnasambönd og notkun þeirra í meðhöndlun á hjartsláttarglöpum
EE200200348A (et) Ravimkoostis kasutamiseks valu ravis
NO20030762L (no) Forbedret spesifisitet i behandling av sykdommer

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees